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We looked into the statistical association of prothrombin time (PT) and activated partial thromboplastin time (APTT) with
disseminated intravascular coagulation (DIC) score calculated using the International society for thrombosis and haemostasis
(ISTH) scoring system. The PT, APTT, PT + APTT, and PT/APTT ratios were evaluated against the DIC score by linear regression
analysisinﬁftyinpatientswithsuspectedDIC.ThePT,PT+APTT,andPT/APTTratioswereallfoundtobestatisticallysigniﬁcant
in predicting DIC scores with P values of 0.02, 0.03, and 0.02, respectively. The APTT alone was not found to be statistically
signiﬁcant in predicting DIC score and had a P value of 0.09. This scoring system does not need d-dimer levels and the platelet
count.
1.Introduction
Disseminated intravascular coagulation (DIC) is character-
ised by intravascular ﬁbrin formation and disturbance of
the microvasculature [1]. It is a complex disorder with mul-
tiple interactions involving hemostasis, ﬁbrinolysis, and in-
ﬂammation. The International Society for Thrombosis and
Haemostasis proposed a deﬁnition and a scoring system for
DIC[2].Thisscoringsystemtakesintoaccountprothrombin
time (PT), ﬁbrinogen levels, levels of ﬁbrin-related marker
and platelet count.
The PT is usually abnormal in DIC but may be normal
andhenc ehasbeentermedasanunr eliabletestinthissetting
[3–6]. PT is prolonged in 50–75% of patients with DIC, and
in 25–50% it is normal or shortened [7]. Activated partial
thromboplastin time (APTT) is prolonged in 50–60% of pa-
tients with DIC, but a normal or shortened APTT may also
be seen [7].
A biphasic clot waveform of APTT has been reported by
some observers as an early event in DIC and noted to have an
adverse outcome by others [8, 9].
The statistical relationship, if any between DIC scores
and PT and APTT, has not been previously reported in the
literature. We undertook this study to evaluate this relation-
ship in ﬁfty patients with underlying conditions associated
with DIC.
2.MaterialsandMethods
We evaluated blood samples from ﬁfty patients (from
February 2011 to June 2011) with underlying condition for
DIC and were clinically suspected of having DIC. All these
patients had bleeding tendencies. No thrombotic episodes
were reported for these patients. None of them were known
tobe onanticoagulantsorhadanypriorbleeding tendencies.
Samples were evaluated at the time of admission.
Blood samples were collected in 3.2gm% trisodium
citrate as anticoagulant (9:1 ratio) and immediately cen-
trifuged at 2500g for ﬁfteen minutes. The PT (Thromborel
S reagent, Siemens), APTT (Dade Actin FSL Activated PTT
reagent, Siemens), ﬁbrinogen (STA-Fibrinogen reagent), and
d-dimer (STA-LIATEST D-DI) were evaluated on the STA
compact analyser. Platelet counts were obtained on the
ADVIA 2120 analyser using EDTA anticoagulated samples.
Control samples were prepared from twenty healthy individ-
uals (equal number of men and women) who were not on
any anticoagulants.2 ISRN Hematology
A DIC score was calculated using the ISTH scoring
system. Platelet count more than 100 × 109 per liter was
given a score of 0, between 50–100 × 109 per liter score of
1 and less than 50 × 109 per liter a score of 2. Elevated ﬁbrin-
related marker was given the score 0 if there was no increase,
2 if there was moderate increase, and 3 if there was strong
increase. A prolonged PT of less than 3 seconds was given
a score of 0, more than 3 and less than 6 was given a score
of 1, and more than 6 was given a score of 2. Fibrinogen
levels below 1g/L were given a score of 0, and levels above
1g/L were given a score of 1. The DIC score was calculated
by adding all these values for the four parameters.
Linear regression analysis with the DIC score as depen-
dant variable on the y-axis and APTT as independent
variable on the x-axis was plotted using Microsoft Excel
Analysis pak tool kit. PT, the sum of PT + APTT, and the
ratio of PT/APTT as independent variables on the x-axis
were plotted likewise against DIC scores on the y-axis. The
ANOVA tables were obtained and P values (signiﬁcant P
value less than 0.05) were calculated. With the regression
coeﬃcient and the intercept, predicted DIC scores were
calculated for the ﬁfty samples using the equation y = a+bx,
where y is the dependant variable (DIC score), a is the
intercept or slope, b is the regression coeﬃcient, and x is the
independent variable.
3. Observations
Among these ﬁfty patients, there were thirty-eight males and
twelve females. They were in the age group of 30–81 years.
Sepsis was the commonest underlying condition for DIC
(Table 1).
The PT was elevated in 46 patients. The diﬀerence of PT
from the control varied from 1–169 seconds.
The APTT was elevated in 41 patients. The diﬀerence of
APTT from the control varied from 2–152 seconds.
Both PT and APTT were together elevated in 41 patients.
An ISTH DIC score of 0 was seen in three of our patients,
score of 1 in two patients, score of 2 in seven patients, score
of 3 in eight patients, score of 4 in sixteen patients, score of 5
in eight patients, and score of 6 in six patients.
The APTT alone was not found to be statistically
signiﬁcant (P value of 0.09) when plotted against DIC scores
(Table 2).
The PT/APTT ratio was found to be statistically signiﬁ-
cant (P value of 0.020) in predicting DIC score (Table 3).
Likewise, PT and PT + APTT were also found to be statis-
tically signiﬁcant (P values of 0.02 and 0.03, resp.) (Tables 4
and 5).
The mean predicted DIC score (Tables 6, 7, 8, 9, 10, 11,
and 12) using PT alone increased from 3.35 to 4.10 for the
ISTH scores of 0–6 except for the ISTH score of 2 where it
was 3.38 which was less than the ISTH score of 1 where it
was 3.42 and score 5 (3.57) which was less than the score of
4 (3.60). The mean score using PT + APTT increased from
3.32–3.93 except for the score of 2 (3.35) which was less than
the score of 1 (3.37). The mean score using PT/APTT ratio
also increased from 3.31–3.92 except for the score of 2 (3.37)
which was less than the score of 1 (3.58).
Table 1: Conditions associated with DIC.
Associated condition Number of patients
Sepsis 26
Trauma 6
Severe hepatic failure 12
Massive blood loss 3
After surgery 2
Leukemia 1
Table 2: ANOVA table for APTT.
Degrees of
freedom
Sum of
squares
Mean
squares F Signiﬁcance
F
Regression 1 7.083 7.083 2.859 0.097
Residual 48 118.917 2.477
Total 49 126
Table 3: ANOVA table for PT/APTT.
Degrees of
freedom
Sum of
squares
Mean
squares F Signiﬁcance
F
Regression 1 13.417 13.417 5.720 0.020
Residual 48 112.582 2.345
Total 49 126
Table 4: ANOVA table for PT.
Degrees of
freedom
Sum of
squares
Mean
squares F Signiﬁcance
F
Regression 1 13.48 13.48 5.75 0.02
Residual 48 112.51 2.34
Total 49 126
Table 5: ANOVA table for PT + APTT.
Degrees of
freedom
Sum of
squares
Mean
squares F Signiﬁcance
F
Regression 1 11.51 11.51 4.82 0.03
Residual 48 114.48 2.38
Total 49 126
4. Discussion
In an appropriate clinical setting DIC is diagnosed with an
elevatedPT,APTT,lowplatelets,andelevatedd-dimerlevels.
However, PT and APTT are not always elevated, and both
normal and shortened times have been reported and as such
they have been found to be unreliable [3–7]. The d-dimer
assay appears to be the most reliable test [7].
In our case series, we proceeded to evaluate the statistical
association of PT and APTT with the DIC scores calculated
usingISTHscoringsystem.Mostofourpatientshadelevated
PT and APTT. None of our patients had a shortened PT or
APTT. The APTT alone did not have statistical signiﬁcance
withtheDICscores.However,PT,PT+APTT,andPT/APTTISRN Hematology 3
Table 6: Predicted DIC scores for the ISTH score of 4. Mean values
for predicted scores are 3.60, 3.57, and 3.67.
ISTH
score
Predicted score
from PT
Predicted score
from PT + APTT
Predicted score
from PT/APTT
4 3.59 3.47 4.12
4 3.72 3.61 4.09
4 3.55 3.72 3.08
4 4.34 4.37 3.79
4 3.46 3.45 3.43
4 4.10 3.96 4.21
4 3.44 3.56 3.05
4 3.48 3.43 3.70
4 3.40 3.43 3.19
4 3.44 3.43 3.43
4 3.72 3.60 4.12
4 3.53 3.48 3.70
4 3.40 3.35 3.55
4 3.44 3.36 3.82
4 3.57 3.51 3.76
4 3.55 3.50 3.73
Table 7: Predicted DIC scores for ISTH score of 5. Mean values for
predicted DIC scores are 3.57, 3.64, and 3.72.
ISTH
score
Predicted score
from PT
Predicted score
from PT + APTT
Predicted score
from PT/APTT
5 3.44 3.56 3.05
5 3.42 3.38 3.52
5 3.53 3.41 4.12
5 3.57 3.47 3.96
5 3.44 3.42 3.49
5 3.53 4.71 2.45
5 4.21 3.82 5.57
5 3.46 3.41 3.67
Table 8: Predicted DIC scores for ISTH score of 3. Mean predicted
values are 3.52, 3.69, and 3.38.
ISTH
score
Predicted score
from PT
Predicted score
from PT + APTT
Predicted score
from PT/APTT
3 3.38 3.36 3.35
3 3.42 3.37 3.55
3 3.65 3.52 4.21
3 3.65 4.19 2.81
3 3.76 4.80 2.63
3 3.40 3.36 3.52
3 3.36 3.32 3.40
3 3.61 3.61 3.58
ratios were found to be statistically signiﬁcant with P values
of 0.02, 0.03, and 0.02, respectively.
As the ISTH scores increased from 0 to 6, our predicted
DICscoresalsoincreasedfrom3.31to3.92(PT/APTTratio),
Table 9: Predicted DIC score for ISTH score of 2. Mean predicted
scores are 3.38, 3.35, and 3.37.
ISTH
score
Predicted score
from PT
Predicted score
from PT + APTT
Predicted score
from PT/APTT
2 3.44 3.37 3.70
2 3.48 3.49 3.43
2 3.34 3.31 3.29
2 3.34 3.31 3.29
2 3.36 3.32 3.40
2 3.34 3.31 3.29
2 3.38 3.39 3.23
Table 10: Predicted DIC score for ISTH score of 6. Mean predicted
scores are 4.10, 3.93, and 3.92.
ISTH
score
Predicted score
from PT
Predicted score
from PT + APTT
Predicted score
from PT/APTT
6 3.48 3.41 3.79
6 3.51 3.58 3.23
6 6.94 6.09 5.09
6 3.55 3.48 3.82
6 3.55 3.49 3.76
6 3.61 3.54 3.88
Table 11: Predicted DIC score for ISTH score of 1. Mean predicted
scores are 3.42, 3.37, and 3.58.
ISTH
score
Predicted score
from PT
Predicted score
from PT + APTT
Predicted score
from PT/APTT
1 3.38 3.33 3.49
1 3.46 3.41 3.67
Table 12: Predicted DIC score for ISTH score of 0. Mean predicted
scores are 3.35, 3.32, and 3.31.
ISTH
score
Predicted score
from PT
Predicted score
from PT + APTT
Predicted score
from PT/APTT
0 3.34 3.31 3.29
0 3.34 3.31 3.29
0 3.38 3.36 3.37
3.32–3.93 (PT + APTT) except for the ISTH score of 1 where
our predicted score was 3.58 (PT/APTT), 3.37 (PT + APTT)
compared to the ISTH score of 2 where our predicted score
was 3.37 (PT/APTT), 3.35 (PT + APTT). There were only
two patients with the ISTH score of 1, one of whom had
minimally elevated PT which would be given a score of 0 in
the ISTH system (as PT elevation of less than 3 seconds were
given a score of 0). However, our system is sensitive to even
minor elevations in PT, making an impact on the predicted
score. The other patient had elevated PT (6 seconds above
control value), but normal platelet count and minimally
elevated d-dimer. With all other scores as the ISTH score
rose, our mean predicted DIC score also increased. Using
PT alone, our predicted score rose comparably except for the
scores of 1 and 5. Like other scoring systems for DIC, our4 ISRN Hematology
system is only relevant in patients who have an underlying
condition associated with DIC. Existing undetected factor
deﬁciencies such as Hageman factor which are not clinically
signiﬁcantwillhaveprofoundeﬀectasAPTTwillbeelevated.
Though our study included many patients with liver disease,
only those patients with elevated d-dimer, whereDIC had set
in were included in the study.
Our paper does not refute the importance of tests for d-
dimer, prothrombin fragment 1 + 2, thrombin antithrom-
bin complex, plasmin antiplasmin complex, decreased
antithrombin III, and other tests used for diagnosing DIC.
Nor does it imply that the scoring systems such as ISTH
can be replaced. We hope this paper can identify groups of
patients who may beneﬁt from replacement therapies (such
as fresh frozen plasma or recombinant factor viia when the
PT/APTT or PT + APTT is rising and withholding fresh
frozen plasma and administration of heparin when these
values are on the decline) and also monitor their eﬃcacy
with repeated calculation of the predicted DIC scores. It
might be argued that a simple elevated PT and APTT can
guide therapy, and there is no need for calculation of the
DIC score. However, minor PT elevations of 1–3 seconds are
ignored and these patients do have underlying conditions for
developmentofDICandtheyneedtobemonitored.Another
scenario where our study could come of use is when there
is a shortened APTT which also tends to be ignored in the
ISTH scoring system. This could also be of great help in
hospitals with limited facilities where a d-dimer test is not
feasible.Plateletcountsonanalysersarenotalwaysreliablein
the presence of giant platelets or red blood cell fragments. As
DIC is complex with variable clinical expression and therapy
needs to be individualized, our paper can be of value in
guiding therapy. Larger studies need to be conducted with
the clinical picture in mind to evaluate the eﬀectiveness of
the predicted DIC score.
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